The acquisition includes a rare immunology disease medicine and an advanced and early-stage immunology pipeline.

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

President Yoweri Museveni has assured Ugandans that the country is now unstoppable in terms of economic growth and ...

Elon Musk's clash with Donald Trump threatens SpaceX’s $22B in U.S. contracts, raising concerns for NASA, national security, ...

On a YTD basis, U.S. trade was a record $1.94 trillion, exports a record $711.20 billion, imports a record $1.22 trillion, ...

Prescription drug cost barriers are increasingly causing people to divert from doctor-recommended treatment plans.

Friedrich Merz is the latest in a string of European leaders who have traveled to the White House in recent weeks in a coordinated campaign to cajole Trump into backing new sanctions on Russia, ...